Essential Tremor Treatment Report

www.EssentialTremorTreatmentReport.com

Clinical Trials

Evaluation of the Infinity Deep Brain Stimulation Electrode Screening Mode Tool

CATEGORY:
Clinical Trials

TITLE:
Evaluation of the Infinity Deep Brain Stimulation Electrode Screening Mode Tool

DESCRIPTION:
Conditions :   Essential Tremor;   Parkinson’s Disease

Intervention :   Device: Clinician programmer electrode screening mode tool

Sponsor :   Abbott Medical Devices

Active, not recruiting

ID:
NCT03794661

DATE – FIRST POSTED:
Mon, 07 Jan 2019 12:00:00 EST

DATE – LAST UPDATE POSTED:
September 30, 2020

DATE – FOUND:
10/04/20 07:52PM

LINK – STUDY HISTORY:
https://clinicaltrials.gov/ct2/history/NCT03794661

LINK – STUDY RECORD:
https://clinicaltrials.gov/ct2/show/NCT03794661

Bilateral Essential Tremor Treatment With Magnetic Resonance-guided Focused Ultrasound (FUS)

https://clinicaltrials.gov/ct2/show/NCT04501484

Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Masking Description: All assessments filmed on video and scored by a blinded evaluator.
Primary Purpose: Treatment
Official Title: Bilateral Essential Tremor Treatment With Magnetic Resonance-guided Focused Ultrasound
Actual Study Start Date : July 8, 2020
Estimated Primary Completion Date : January 2021
Estimated Study Completion Date : October 2024

Bilateral Essential Tremor Treatment With FUS (BEST-FUS)

ClinicalTrials.gov Identifier: NCT04501484
Recruitment Status : Recruiting
First Posted : August 6, 2020
Last Update Posted : August 6, 2020

Trial of Cannabis for Essential Tremor

https://clinicaltrials.gov/ct2/show/NCT03805750

Trial of Cannabis for Essential Tremor
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03805750
Recruitment Status : Recruiting
First Posted : January 16, 2019
Last Update Posted : May 29, 2020

Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 16 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Double-Blind, Cross-Over, Placebo- Controlled Efficacy and Tolerability Study of Oral Cannabidiol (CBD) and Tetrahydrocannabinol (THC) for Essential Tremor (ET).
Actual Study Start Date : January 22, 2019
Estimated Primary Completion Date : September 2020
Estimated Study Completion Date : December 2020

Back to top